Development and early diagnosis of critical illness myopathy in COVID-19 associated acute respiratory distress syndrome.

Belén RodriguezMattia BrancaMarielena Gutt-WillMarianne RothNicole SöllSandra NansozDavid R CameronHatice TankisiS Veronica TanHugh BostockAndreas RaabeJoerg C SchefoldStephan M JakobWerner J Z'Graggen

Published in: Journal of cachexia, sarcopenia and muscle (2022)

This study reports a 55% prevalence of definite CIM in critically ill COVID-19 patients. Furthermore, the results confirm that muscle excitability measurements may serve as an alternative method for CIM diagnosis and support its use as a tool for early diagnosis and monitoring the development of CIM.

Keyphrases

acute respiratory distress syndrome
sars cov
extracorporeal membrane oxygenation
mechanical ventilation
coronavirus disease
risk factors
skeletal muscle
late onset
emergency department
intensive care unit
transcranial direct current stimulation
respiratory syndrome coronavirus
muscular dystrophy